LOTUS PHARMCEUTICAL CO.,LTD

Business Nature: Manufacturer (Pharmaceutical Manufacturer)

Company Overview:

Lotus Pharmaceutical Co., Ltd. is a leading multinational pharmaceutical company headquartered in Taiwan. Established in 1966, the company has evolved into a key player in the global healthcare market, specializing in the research, development, and manufacturing of high-quality generic and specialty pharmaceuticals.

Key Operations:

Manufacturing: Lotus operates advanced, GMP-certified manufacturing facilities that adhere to international quality standards, including US FDA and EU GMP approvals. They have strong capabilities in developing complex oral solid dosage forms.

R&D: The company maintains a robust research and development pipeline, focusing on high-barrier products such as oncology, cardiovascular, and central nervous system medications.

Global Reach: Lotus has an extensive commercial footprint, with a direct presence in numerous markets across Asia and a well-established export network serving North America, Europe, and other international regions.

Strategic Focus:

The company is widely recognized for its expertise in the generic drug industry and its strategic partnerships with global pharmaceutical leaders. Lotus is committed to improving patient access to affordable, life-saving medications through continuous innovation and operational excellence.

Lotus Pharmaceutical Co., Ltd. Product Portfolio

Therapeutic Areas and Key Products:

Oncology

Lenalidomide (Treatment for multiple myeloma and myelodysplastic syndromes)

Pomalidomide (Treatment for multiple myeloma)

Capecitabine (Treatment for breast, colon, and colorectal cancer)

Tegafur/Uracil (Treatment for various solid tumors)

Anastrozole (Treatment for breast cancer)

Bicalutamide (Treatment for prostate cancer)

Cardiovascular

Rosuvastatin (Treatment for hypercholesterolemia)

Atorvastatin (Treatment for hypercholesterolemia)

Telmisartan (Treatment for hypertension)

Bisoprolol (Treatment for hypertension and heart failure)

Clopidogrel (Antiplatelet agent to prevent blood clots)

Central Nervous System

Quetiapine (Treatment for schizophrenia and bipolar disorder)

Donepezil (Treatment for Alzheimer’s disease)

Methylphenidate (Treatment for ADHD)

Metabolic and Endocrine

Metformin (Treatment for type 2 diabetes)

Glimepiride (Treatment for type 2 diabetes)

Gastrointestinal

Esomeprazole (Treatment for GERD and gastric ulcers)

Pantoprazole (Treatment for GERD and gastric ulcers)

Respiratory

Montelukast (Treatment for asthma and allergic rhinitis)

Note: Product availability may vary by region and regulatory approval. This list represents the company's core generic and specialty pharmaceutical offerings.